Litcius/Paper detail

Passive anti-amyloid β immunotherapy in Alzheimer's disease—opportunities and challenges

Michael T. Heneka, David Morgan, Frank Jessen

2024The Lancet75 citationsDOI

Topics & Concepts

ImmunotherapyAlzheimer's diseaseMedicineAmyloid βAmyloid (mycology)DiseaseImmunologyImmune systemPathologyAlzheimer's disease research and treatmentsTryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms
Passive anti-amyloid β immunotherapy in Alzheimer's disease—opportunities and challenges | Litcius